VRC-HIVADV052-00-VPAlternative Names: HIV vaccine rAd5-Env-B VRC; rAd5 env B; rAd5 HIV vaccine VRC Env-B; rAd5-EnvB vaccine; VRC-rAd5 HIV vaccine Env-B
Latest Information Update: 16 Jul 2016
At a glance
- Originator GenVec
- Developer GenVec; Vaccine Research Center
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in HIV-1-infections(Prevention, In volunteers) in USA (IM)